Pancragen
Pancragen (Lys-Glu-Asp-Trp)
A tetrapeptide bioregulator derived from pancreatic tissue. Part of the Russian peptide bioregulator series. Supports pancreatic function and glucose metabolism.
Mechanism of Action
Pancragen modulates gene expression in pancreatic beta cells and acinar cells, supporting insulin secretion, reducing pancreatic oxidative stress, and promoting pancreatic cell survival.
Health Claims & Evidence
Supports pancreatic function and insulin secretion
May improve glucose metabolism
Reduces pancreatic oxidative stress
Short-Term Effects
Potential improvements in glucose metabolism markers.
Long-Term Effects
Theoretical pancreatic protection with repeated courses.
Side Effects
Extremely well-tolerated.
Contraindications
Use with caution in diabetes — monitor glucose carefully.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Pancragen and pancreatic bioregulation
Khavinson et al. · Bulletin of Experimental Biology and Medicine · 2013
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Pancragen and related peptides, and prepare an educational research summary.
Explore Research